Click Down Arrow to See FDA Compliance Guidance Details
Prohibition on Free Samples “FDA wishes to clarify that allowing prospective adult buyers to smell or handle a cigar is not considered the distribution of a “free sample” as long as the product is not actually consumed in the retail facility and the prospective buyer does not leave the facility with a free tobacco product (whole or part). . . . However, if the prospective buyer lights and draws or puffs on the cigar to keep the cigar lit, or otherwise uses the free cigar or leaves the retail establishment with a free cigar, this would constitute a “free sample” in violation of” FDA regulation.
Minimum Age and Identification Requirements Can not say or imply in labeling or advertising that a product has a lower risk of disease, is less harmful, or that it contains a reduced level or is free from any substance. Enforcement action against products determined to be adulterated or misbranded If you fail to take any required action listed here or in future regulations, or if FDA determines that the products are contaminated by an added substance that may cause injury, then FDA can deem the products “adulterated” or “misbranded” under the law. That determination permits FDA to take enforcement action (e.g., Warning Letters, product seizure, injunction, fines).
Submission of Cigar 'Warning Plan' to FDA Retailers who are responsible for or direct their own cigar advertising must submit a “warning plan” to FDA for those advertisements.
Manufacturers are Required to Register and List Products According to the final rule, “retail establishments that blend pipe tobacco, are subject to and must comply with all applicable statutory and regulatory requirements for tobacco product manufacturers” (see below).
Point-of-sale warnings For cigars sold individually and not in a product package, all of the cigar warnings must be placed on a sign a minimum of 8.5 x 11 inches posted on or within 3 inches of each cash register.
Click Down Arrow to See FDA Compliance Guidance Details
Enforcement action against products determined to be adulterated or misbranded If you fail to take any required action listed here or in future regulations, or if FDA determines that the products are contaminated by an added substance that may cause injury, then FDA can deem the products “adulterated” or “misbranded” under the law. That determination permits FDA to take enforcement action (e.g., Warning Letters, product seizure, injunction, fines).
First report due for user fees Domestic manufacturers and importers of cigars and pipe tobacco must submit information to FDA for purposes of calculating user fees. “Domestic manufacturer” means a person who is required to obtain a permit from ATTTB of the Department of the Treasury for the production of tobacco products. “Importer” means a person who is required to obtain a permit from ATTTB of the Department of the Treasury for the importation of tobacco products. Domestic manufacturers and importers of cigars and pipe tobacco will start being assessed fees at the start of the fiscal year following the effective date of the rule. User fees will then be assessed quarterly.
Submission of cigar Warning Plan to FDA. Required warnings to be randomly displayed in each 12-month period, in as equal a number of times as is possible on each brand of cigar sold in product packaging and randomly distributed in all areas of the United States. For advertisements, the warnings must be rotated quarterly in alternating sequence in each advertisement for each brand of cigar.
Extended deadline for domestic manufacturers to register and list products. Foreign manufacturers will be required to register and list too, but this will require a separate registration with its own effective date. Registration: Listing: Can not say or imply in labeling or advertising that a product has a lower risk of disease, is less harmful, or that it contains a reduced level or is free from any substance. Prohibition on free samples. Premarket review requirements (SE, SE exempt, and PMTA) apply to all products not on the market as of August 8, 2016 unless “grandfathered.” For products marketed before August 8, 2016 but not “grandfathered,” enforcement is delayed if submitted and/or under review by certain dates (see “Premarket Review Compliance Periods” below). Notify FDA if adding a new additive or increasing the quantity of an existing additive 90 days before making such change.
Prohibition against the use of light, low, and mild descriptors. These terms or “other unauthorized modified risk claims” are prohibited. Plus an additional 30-day period in which a manufacturer may continue to distribute existing inventory manufactured before the effective date.
Submission of Health Documents by domestic manufacturers and importers (or the foreign manufacturer) Small-scale tobacco product manufacturers have an extra 6 months. [1] FDA intends to publish guidance that specifies the scope of such health documents within three to six months of the publication date of the final rule. Manufacturers and importers must preserve all tobacco health documents developed after June 22, 2009 for future submissions to FDA.
Domestic manufacturers and importers or the foreign manufacturer must submit ingredient lists but not HPHCs Small-scale tobacco product manufacturers have 12 months from the effective date of the final rule. [2]
Required health warnings and other required labeling statements. Required health warnings in advertising. Pesticide levels in domestic or foreign tobacco can not be greater than that specified by any tolerance applicable under federal law to domestic tobacco.
Extended Deadline for Small Manufacturers in FEMA Designated Disaster Areas
HPHC reporting for all constituents including smoke constituents under 904(a)(3). Required HPHC reporting under 915 will require a separate regulation.
Last day to submit SE reports for products marketed before August 8, 2016 but not “grandfathered.”
Last Day to submit PMTA for products marketed before August 8, 2016 but not “grandfathered.”
Compliance date for manufacturers to submit a substantial equivalence exemption request (§910oftheFD&CAct) for non-combustible tobacco products, such as cigars or pipes.
Compliance date for manufacturers to submit a premarket tobacco product application (PMTA)(§905of the FD&C Act) for non-combustible tobacco products such as cigars or pipes.
For newly deemed products that are on the market on the effective date of the final rule and were not on the market on February 15, 2007:
August 8, 2016 to August 8, 2017
Manufacturer may submit an SE exemption request (however, FDA can “refuse-to-accept” an incomplete SE exemption request, and then it is not considered submitted).
August 8, 2016 to February 8, 2018
Manufacturer may submit an SE report (however, FDA can “refuse-to-accept” an incomplete SE report, and then it is not considered submitted).
August 8, 2016 to August 8, 2018
Manufacturer may submit a PMTA (however, FDA can “refuse-to-accept” an incomplete PMTA, and then it is not considered submitted).
If the manufacturer submits and FDA accepts one of the submissions by the deadline stated above, FDA will not take enforcement action against that product for one year. However, at the end of that period, even if FDA has not completed its review, the product will be subject to enforcement action unless FDA determines that “substantial progress” is being made towards completion.
Blending changes to address the natural variation of tobacco in order to maintain a consistent product do not require preauthorization, but the ingredients must be listed. Blending changes intended to alter the chemical or perception of the product (e.g., nicotine level, pH, smoothness, or harshness, etc.), including seasonal and limited release products, do require premarket authorization.